Max Jonson
Finanzdirektor/CFO bei BURE EQUITY AB
Vermögen: 807 918 $ am 30.04.2024
Aktive Positionen von Max Jonson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BURE EQUITY AB | Finanzdirektor/CFO | 01.10.2013 | - |
Investor Relations Kontakt | 31.12.2013 | - | |
Skanditek AB | Direktor/Vorstandsmitglied | - | - |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Direktor/Vorstandsmitglied | - | - |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | - | - |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Finanzdirektor/CFO | 01.09.2013 | - |
Private Equity Investor | 01.09.2013 | - |
Karriereverlauf von Max Jonson
Ehemalige bekannte Positionen von Max Jonson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Celemi International AB | Direktor/Vorstandsmitglied | 01.01.2016 | 01.01.2018 |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Direktor/Vorstandsmitglied | 01.01.2016 | 01.01.2017 |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Direktor/Vorstandsmitglied | 01.01.2014 | 01.01.2016 |
Stockholm School of Economics Ifl | Finanzdirektor/CFO | 01.01.2012 | 01.01.2013 |
░░░ ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░ ░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Max Jonson
The University of Chicago | Masters Business Admin |
New York University | Undergraduate Degree |
Statistik
International
Schweden | 17 |
Vereinigte Staaten | 3 |
Operativ
Director of Finance/CFO | 8 |
Director/Board Member | 7 |
Undergraduate Degree | 1 |
Sektoral
Finance | 5 |
Consumer Services | 4 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BURE EQUITY AB | Finance |
YUBICO AB | Distribution Services |
Private Unternehmen | 13 |
---|---|
Orasolv AB
Orasolv AB Medical/Nursing ServicesHealth Services Orasolv AB engages in the provision of dental care. It acquires, develops, and manages practices within the dental sector, as well as delivers consultancy services to Swedish dentists. The firm also operates a chain of dental clinics. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Health Services |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Finance |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Commercial Services |
Dpnova AB
Dpnova AB Medical/Nursing ServicesHealth Services DPNOVA, headquartered in Malmö, is the leading dental laboratory in Sweden with over 207 MSEK in revenue over 250 employees across five locations (Malmö, Stockholm, Göteborg, Sjöbo, and Jönköping). Started in 1950, DPNOVA delivers a full range of dental lab services to dentists. | Health Services |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Health Technology |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
Atle Investment Management AB | |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Finance |
Celemi International AB | |
SEB Group (Sweden) | |
ACQ Bure AB
ACQ Bure AB Financial ConglomeratesFinance ACQ Bure AB is a non-operational acquisition company. Its investment strategy is to identify and complete an acquisition of a company that can create value for the shareholders over time. The company was founded on October 26, 2020 and is headquartered in Stockholm, Sweden. | Finance |
Skanditek AB | |
Sse Executive Education |
- Börse
- Insiders
- Max Jonson
- Erfahrung